Scarica l'app Stockscreener
0.7079
0.24%
-0.0017
Dopo l'orario di chiusura:
.70
-0.0079
-1.12%
Precedente Chiudi:
$0.7096
Aprire:
$0.7085
Volume 24 ore:
131.63K
Relative Volume:
0.47
Capitalizzazione di mercato:
$54.40M
Reddito:
$9.53M
Utile/perdita netta:
$-44.61M
Rapporto P/E:
-0.7779
EPS:
-0.91
Flusso di cassa netto:
$-38.32M
1 W Prestazione:
-1.99%
1M Prestazione:
-14.30%
6M Prestazione:
-31.27%
1 anno Prestazione:
+46.05%
Intervallo 1D:
$0.695
$0.7136
Intervallo di 1 settimana:
$0.6721
$0.78
Portata 52W:
$0.45
$1.9891
Cue Biopharma Inc Stock (CUE) Company Profile
Nome
Cue Biopharma Inc
Settore
Industria
Telefono
617-949-2680
Indirizzo
40 GUEST STREET, BOSTON, MA
Confronta CUE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CUE
Cue Biopharma Inc
|
0.7079 | 54.53M | 9.53M | -44.61M | -38.32M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
376.62 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.98 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.37 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
729.76 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
329.84 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Cue Biopharma Inc Stock (CUE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-03-13 | Iniziato | Jefferies | Buy |
| 2023-06-26 | Ripresa | Oppenheimer | Outperform |
| 2022-11-21 | Iniziato | Piper Sandler | Overweight |
| 2022-01-13 | Iniziato | H.C. Wainwright | Buy |
| 2022-01-03 | Iniziato | Craig Hallum | Buy |
| 2020-11-24 | Iniziato | Berenberg | Buy |
| 2020-04-09 | Iniziato | Stifel | Buy |
| 2020-01-28 | Iniziato | BTIG Research | Buy |
| 2020-01-22 | Iniziato | JMP Securities | Mkt Outperform |
Mostra tutto
Cue Biopharma Inc Borsa (CUE) Ultime notizie
How to build a custom watchlist for Cue Biopharma Inc.Recession Risk & Fast Entry Momentum Trade Alerts - newser.com
Market reaction to Cue Biopharma Inc.’s recent newsJuly 2025 Intraday Action & Daily Volume Surge Signals - newser.com
Building trade automation scripts for Cue Biopharma Inc.July 2025 Pullbacks & Daily Stock Trend Watchlist - newser.com
Will breakout in Cue Biopharma Inc. lead to full recoveryPortfolio Value Report & Weekly Hot Stock Watchlists - newser.com
Analyzing Cue Biopharma Inc. with risk reward ratio chartsQuarterly Profit Report & Free Weekly Watchlist of Top Performers - newser.com
Aug Setups: Can Cue Biopharma Inc disrupt its industryTake Profit & Fast Gain Swing Alerts - khodrobank.com
Real time breakdown of Cue Biopharma Inc. stock performanceMarket Sentiment Summary & AI Forecast for Swing Trade Picks - newser.com
Trade Recap: Is Cue Biopharma Inc stock good for income investorsJuly 2025 Technicals & Smart Allocation Stock Reports - خودرو بانک
Does Cue Biopharma Inc. meet Warren Buffett’s criteriaPortfolio Value Report & Smart Investment Allocation Insights - خودرو بانک
Is a relief rally coming for Cue Biopharma Inc. holdersEarnings Risk Report & Technical Confirmation Alerts - newser.com
Is Cue Biopharma Inc. stock bottoming outMarket Risk Summary & Fast Moving Market Watchlists - newser.com
Short Squeeze: Does Cue Biopharma Inc align with a passive investing strategy2025 Price Action Summary & AI Forecasted Entry/Exit Points - خودرو بانک
Reversal indicators forming on Cue Biopharma Inc. stockJuly 2025 Closing Moves & Verified Momentum Stock Ideas - newser.com
Can a trend reversal in Cue Biopharma Inc. lead to recoveryEarnings Overview Summary & Risk Managed Trade Strategies - newser.com
Is Cue Biopharma Inc still a buy after recent gainsEarnings Trend Report & Accurate Intraday Trade Tips - خودرو بانک
Will Cue Biopharma Inc. continue its uptrendWeekly Stock Summary & Verified Entry Point Signals - newser.com
Detecting support and resistance levels for Cue Biopharma Inc.Quarterly Trade Review & High Win Rate Trade Tips - newser.com
Support Test: What is Cue Biopharma Incs 5 year growth outlook2025 Sector Review & Momentum Based Trading Ideas - خودرو بانک
Should you hold or exit Cue Biopharma Inc. nowPortfolio Gains Report & Technical Confirmation Trade Alerts - newser.com
Nasdaq Moves: Is Cue Biopharma Inc. subject to activist investor interestMarket Risk Summary & Scalable Portfolio Growth Methods - khodrobank.com
What’s next for Cue Biopharma Inc. stock priceTrade Volume Report & Consistent Return Strategy Ideas - newser.com
Will earnings trigger a reversal in Cue Biopharma Inc.2025 Top Gainers & Verified Short-Term Trading Plans - newser.com
Published on: 2025-09-17 05:49:57 - newser.com
Developing predictive dashboards with Cue Biopharma Inc. dataPortfolio Gains Report & Risk Managed Investment Strategies - newser.com
Volume Report: Is Cue Biopharma Inc stock forming a triangle pattern2025 Key Highlights & Weekly Chart Analysis and Trade Guides - khodrobank.com
Sentiment Watch: Whats the profit margin of Cue Biopharma IncStock Surge & Risk Controlled Swing Trade Alerts - خودرو بانک
Rate Cut: Can Cue Biopharma Inc disrupt its industryWeekly Investment Summary & Weekly Watchlist for Consistent Profits - خودرو بانک
Is Cue Biopharma Inc. stock a good pick for beginners2025 Investor Takeaways & Reliable Price Breakout Signals - خودرو بانک
Aug Technicals: Will Cue Biopharma Inc benefit from geopolitical trends2025 Major Catalysts & Free Real-Time Volume Trigger Notifications - خودرو بانک
Can swing trading help recover from Cue Biopharma Inc. lossesPortfolio Update Summary & Entry Point Strategy Guides - newser.com
Market Moves: Should I add Cue Biopharma Inc. stock to my portfolioJuly 2025 Short Interest & Weekly High Return Stock Opportunities - خودرو بانک
What to do if you’re stuck in Cue Biopharma Inc.Quarterly Earnings Summary & Verified Stock Trade Ideas - newser.com
Published on: 2025-09-14 00:20:21 - newser.com
Cue Biopharma Inc Azioni (CUE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.30%
2.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):